New vibrating vest aims to make lung clearance easier for chronic lung patients
NCT ID NCT07175012
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a wearable vest called ELECTROVEST that vibrates and gently stimulates muscles to help clear mucus from the lungs. It included 21 adults with COPD, cystic fibrosis, bronchiectasis, or asthma. The vest was compared to a standard chest-vibration device to see if it was more comfortable and effective at removing sputum.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Electrostimulation vibratory vest (ELECTROVEST)
- What this could lead to
- If it works, this vest could offer a more comfortable and effective way to clear mucus from the lungs, improving breathing and quality of life for people with chronic lung diseases.
- What could go wrong
- This was a small, early-stage trial with only 21 participants, so results may not apply to everyone. The device is not a cure and only helps manage symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
21 people
The number who actually took part.
- Started
-
Oct 2023
- Finished
-
May 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
16 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with Chronic Respiratory Diseases Diagnosed with chronic respiratory disease with bronchial hypersecretion: COPD, cystic fibrosis, bronchiectasis, or asthma * Age \>16 years * Clinically stable (no exacerbations in past 4 weeks) Exclusion Criteria: * Risk of pneumothorax and/or barotrauma * Risk or history of hemoptysis * On active waiting list for lung transplant or surgery * Musculoskeletal or other limiting condition * Diagnosis of osteoporosis
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Asthma bronchiale are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Universitario Virgen del Rocío
Seville, Sevilla, 41013, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Patient's own airway stem cells repair damaged lungs in COPD?
- Glucose sensor may flag diabetes risk in cystic fibrosis
- Six biologics put to the test in Real-World asthma and COPD care
- Can a breathing routine ease COPD breathlessness?
- Switching to a nebulizer may help COPD patients who get no relief from inhalers
- Can extra oxygen during rehab change how COPD patients breathe?